1. Home
  2. CRON vs PAXS Comparison

CRON vs PAXS Comparison

Compare CRON & PAXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRON
  • PAXS
  • Stock Information
  • Founded
  • CRON N/A
  • PAXS 2021
  • Country
  • CRON Canada
  • PAXS United States
  • Employees
  • CRON N/A
  • PAXS N/A
  • Industry
  • CRON Medicinal Chemicals and Botanical Products
  • PAXS Investment Managers
  • Sector
  • CRON Health Care
  • PAXS Finance
  • Exchange
  • CRON Nasdaq
  • PAXS Nasdaq
  • Market Cap
  • CRON 684.7M
  • PAXS 717.7M
  • IPO Year
  • CRON N/A
  • PAXS N/A
  • Fundamental
  • Price
  • CRON $1.92
  • PAXS $15.09
  • Analyst Decision
  • CRON
  • PAXS
  • Analyst Count
  • CRON 0
  • PAXS 0
  • Target Price
  • CRON N/A
  • PAXS N/A
  • AVG Volume (30 Days)
  • CRON 2.0M
  • PAXS 195.0K
  • Earning Date
  • CRON 05-08-2025
  • PAXS 01-01-0001
  • Dividend Yield
  • CRON N/A
  • PAXS 11.72%
  • EPS Growth
  • CRON N/A
  • PAXS N/A
  • EPS
  • CRON 0.13
  • PAXS N/A
  • Revenue
  • CRON $124,589,000.00
  • PAXS N/A
  • Revenue This Year
  • CRON $25.49
  • PAXS N/A
  • Revenue Next Year
  • CRON $7.45
  • PAXS N/A
  • P/E Ratio
  • CRON $15.47
  • PAXS N/A
  • Revenue Growth
  • CRON 33.92
  • PAXS N/A
  • 52 Week Low
  • CRON $1.60
  • PAXS $12.57
  • 52 Week High
  • CRON $2.64
  • PAXS $15.93
  • Technical
  • Relative Strength Index (RSI)
  • CRON 44.96
  • PAXS 49.87
  • Support Level
  • CRON $1.98
  • PAXS $14.58
  • Resistance Level
  • CRON $2.07
  • PAXS $15.32
  • Average True Range (ATR)
  • CRON 0.07
  • PAXS 0.19
  • MACD
  • CRON -0.02
  • PAXS 0.01
  • Stochastic Oscillator
  • CRON 4.17
  • PAXS 68.92

About CRON Cronos Group Inc. Common Share

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About PAXS PIMCO Access Income Fund of Beneficial Interest

PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.

Share on Social Networks: